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Abstract The cyclosome pathway of ubiquitin-mediated pro-
teolysis plays an essential role in cell cycle control. The
multisubunit cyclosome is regulated by transient interactions
with Fizzy (Fzy) and Fizzy-related (Fzr) genes. We report here
that both Fzy and Fzr are transcribed in a cell cycle specific but
distinct manner. Fzy transcription starts after the restriction
point in late G1 and ceases upon cell division. Fzr transcription
also ceases upon cell division but resumes already in mid G1,
before the restriction point, and takes place also in G0. Fzr has
further a striking cell cycle specific pattern of mRNA stability.
During most of the cell cycle its message is fairly stable, however
upon exit from mitosis it is rapidly degraded. This result is
puzzling because Fzr is essential for cyclosome activity in G1,
and points to a complex pattern of Fzr regulation.
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1. Introduction
Ubiquitin-mediated proteolysis plays a major role in the
control of the eukaryotic cell cycle [1]. Programmed proteo-
lysis ensures that cells contain di¡erent sets of key regulators
at di¡erent times of the cell cycle. Many of these key regula-
tors control the activity and speci¢city of protein kinases
which in turn a¡ect the behavior of whole sets of proteins
involved in DNA replication, chromosome segregation and
cell division. By controlling the set of key regulators, proteo-
lysis largely dictates the orderly succession of the di¡erent cell
cycle phases.
The mitotic A and B type cyclins were the ¢rst known
examples of cell cycle regulators controlled by ubiquitin-medi-
ated proteolysis. The abrupt degradation of these proteins
starts during mitosis and requires a conserved nine amino
acid long ‘destruction box’ [2,3] in their N-terminal region.
The degradation of these cyclins is essential for the cell to
complete mitosis [4]. Lately several other mitotic factors:
Pds1 [5], Ase1 [6], Cut2 [7], Scc1 [8], Cdc5 [9] and Cdc20
[10] have been identi¢ed as substrates of the same destruction
box speci¢c proteolysis pathway.
The speci¢c key component for ubiquitination of destruc-
tion box substrates, is a large, 12 subunit complex of about
1500 kDa called cyclosome or anaphase promoting complex
(APC) [11,12]. The cyclosome has a cell cycle speci¢c activity
which is not restricted to mitosis but persists throughout G1
and even in G0 and in di¡erentiated cells [13].
Genetic studies in Drosophila [14,15] and yeast [16^18] have
identi¢ed two additional proteins which play essential roles in
the regulation of the cyclosome. These proteins fall into two
closely related groups of WD repeat proteins [19]. One group,
Fzy, includes Cdc20 (Saccharomyces cerevisiae), Slp1 (Schizo-
saccharomyces pombe), Fizzy (Drosophila) and p55cdc (mam-
mals) and the second group, Fzr, includes Cdh1/Hct1 (S. cere-
visiae) and Fizzy related (Drosophila, Xenopus and mammals).
These proteins activate the cyclosome at di¡erent phases of
the cell cycle and possibly towards di¡erent substrates [20].
Fzy is involved in the degradation during the metaphase-ana-
phase transition and Fzr in the degradation in late mitosis and
during G1. Several recent results have shown that Fzy, but
not Fzr, is part of the mitotic spindle checkpoint mechanism
[21,22].
The mammalian Fzy homologue p55cdc has been cloned
and studied [23,24]. Its protein levels oscillate throughout
the cell cycle and it is a substrate of ubiquitin-mediated pro-
teolysis [24]. The mammalian Fzr homologue has been cloned
by several labs [25,26] and its protein is present throughout
the cell cycle. The patterns of Fzy and Fzr transcription dur-
ing Drosophila embryogenesis are very distinct. Fzy expres-
sion is correlated with mitotic cell cycle progression, Fzr is
not. Fzr transcript levels are strongly up-regulated when cells
become postmitotic. Importantly, genetic analysis has clearly
demonstrated that this up-regulation is essential to arrest cell
proliferation at the appropriate developmental stage [15].
We have studied the expression pattern of mouse Fzy and
Fzr during the cell cycle and found that the two genes display
a distinct cell cycle speci¢c transcription pattern. Fzy tran-
scription is very similar to that of cyclin B1 [27^29] and B2
[13] starting in late G1 or early S phase and persisting
throughout mitosis. Fzy transcription ceases upon cell divi-
sion and its mRNA levels decline gradually during the ¢rst
hours of G1. Fzr transcription is also cell cycle speci¢c but it
follows a di¡erent and unique pattern starting in G1 before
the restriction point. While it is so far unclear to what extend
Fzr is transcribed in S and G2, we found that it is not tran-
scribed in early G1. This was an unexpected observation be-
cause Fzr is essential for cyclosome activation during G1. We
were even more surprised to ¢nd that Fzr mRNA, which is
normally rather stable, gets speci¢cally degraded upon cyto-
kinesis. These results suggest that both Fzy and Fzr are regu-
lated in a complex manner at multiple levels of synthesis and
degradation.
2. Materials and methods
2.1. Fzy and Fzr cDNA clones
Two EST clones of high homology to the Xenopus Fzr gene
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(Y14163) were obtained from the IMAGE consortium and sequenced.
EST 724-a13 coded for amino acids 1^360 and EST 2640-n23 for
amino acids 388^493. The missing part of the gene was obtained by
RT-PCR of HeLa cDNA. The three parts of the gene were used to
construct a full length cDNA using conventional molecular biology
methods [30]. A full length human Fzy (p55cdc) EST clone (656-h22)
was obtained and sequenced [31] and found to be identical to the
p55cdc described by Weinstein et al. [23].
2.2. Tissue culture
Murine NIH3T3 ¢broblasts were obtained from R. Treisman
(ICRF, London) and grown in DMEM supplemented with 10%
FCS, glutamine, penicillin and streptomycin, all purchased from Bio-
logical Industries, Beit Haemek. Prometaphase arrested cells were
obtained by overnight treatment with 2 WM nocodazole (Sigma) fol-
lowed by shake-o¡ of the cells arrested in prometaphase. This method
yields a viable and highly synchronous population of cells which,
when released into fresh medium, is capable of proceeding synchro-
nously into G1 [13]. Actinomycin D (Sigma) was dissolved in ethanol
as described [32], and used at 10 Wg/ml ¢nal concentration.
2.3. RNA and protein blotting
Total RNA was prepared by the Guanidinium Isothiocyanate
method [33] and quantitated by optical density. One percent agarose
gels were prepared with MOPS bu¡er supplemented with 0.66 M
formaldehyde, as described [34]. Equal amounts of RNA were run
for approximately 3 h in MOPS bu¡er without formaldehyde and
subsequently blotted for 16 h by capillary transfer onto Hybond
N+ charged nylon membranes (Amersham). The blots were hybrid-
ized [32] with 32P-radiolabeled Fzy, Fzr and Myc speci¢c probes.
After hybridization the blots were washed and exposed to a phosphor-
imager screen (Fuji). Immunoblots of Fzy were performed by stand-
ard methods [35] with goat anti-Fzy (p55cdc) antibodies (SCB).
3. Results
3.1. Mouse Fizzy and Fizzy-related genes are transcribed in cell
cycle speci¢c and distinct patterns
Cell cycle speci¢c interactions of Fzy and Fzr with the
cyclosome play an essential role in its activation to degrade
di¡erent substrates. In order to study the cell cycle speci¢c
expression of these two factors we obtained human cDNA
clones of both genes. The human EST clone 656-h22 was
sequenced and found to be identical to the published Fzy
cDNA, p55cdc [23]. The human Fzr was constructed of two
EST clones and a short fragment ampli¢ed by RT-PCR as
described in Section 2. This assembled cDNA was sequenced
and the coded protein was found to be 95 and 68% identical
to the Xenopus and Drosophila Fzr [15] respectively, compared
to only 40% identity between the human Fzy and Fzr pro-
teins.
Mouse NIH3T3 ¢broblasts were synchronized by nocoda-
zole arrest and shake-o¡ which yields a highly synchronous
population of prometaphase cells [13]. The cells were then
released into fresh medium and harvested at 2 h intervals
for FACS analysis (Fig. 1A), immunoblot with a goat anti-
Fzy antibody (Fig. 1B) and RNA blot with Fzy and Fzr
speci¢c radio-labeled probes (Fig. 1C). At time point 0 almost
all the cells were mitotic as judged from their rounded shape,
condensed chromosomes and DNA content. Upon release
into fresh medium cells divided and entered G1. They entered
S phase between 8 and 10 h after release, G2 at 14 h and
again G1 at 18 h.
The levels of Fzy protein, as detected by immunoblotting
(Fig. 1B), oscillated sharply during the cell cycle. Fzy rapidly
disappeared upon entry into G1 and remained undetectable
until the onset of S phase, when it started to accumulate to
peak levels in G2-M. These results are consistent with pre-
vious reports [24] and are identical to the oscillations of the
cyclin B1 protein during the cell cycle [13]. Due to low con-
centrations of Fzr in the cell and to the lack of a good anti-
body we could not properly follow the changes of Fzr during
the cell cycle. Fzr has however previously been reported to be
present at fairly constant levels throughout the cell cycle [25].
RNA prepared from the di¡erent time points was analyzed
by Northern blotting with Fzy and Fzr speci¢c probes (Fig.
1C). Both messages oscillate sharply during the cell cycle but
in a very distinct pattern (Fig. 1D). Fzy mRNA slowly de-
clines upon release from the nocodazole arrest reaching un-
detectable levels within a few hours in G1 and starting to rise
again in early S phase to peak levels in G2. This behavior is
reminiscent of the oscillations of cyclin B [13]. The Fzr mes-
sage also peaks in mitosis but declines much faster upon re-
lease from nocodazole arrest and is already undetectable after
2 h. It starts however to rise in mid G1, several hours before
the Fzy message.
The di¡erence in the initiation of Fzr transcription is clearly
Fig. 1. Fzy protein and mRNA levels, as well as Fzr mRNA levels
oscillate during the cell cycle. NIH3T3 ¢broblasts were treated with
nocodazole for 16 h and the prometaphase arrested cells were ob-
tained by mitotic shake-o¡. Cells were then cultured in fresh me-
dium and harvested at the indicated times. A: The cells at the dif-
ferent time points were analyzed by £ow cytometry to assess their
position in the cell cycle. B: Immunoblot of cell extracts with an
anti-Fzy antibody. C: RNA blot with 32P-labeled Fzy and Fzr spe-
ci¢c probes. The Fzr speci¢c probe was contaminated with bacterial
RNA which cross-reacted with the 18S ribosomal RNA of each
sample yielding a convenient standard to the mRNA loading of the
di¡erent lanes of the gel. D: The relative mRNA levels of Fzy and
Fzr were quantitated by a Fuji phosphorimager, normalized against
the levels of 18S ribosomal RNA and plotted in relation to the per-
centage of S phase cells (grey shaded area).
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manifested in the observation (Fig. 2) that Fzr mRNA is
present at high levels in cells arrested in G0 by serum starva-
tion, as well as in a highly di¡erentiated tissue like the brain.
3.2. Fzr mRNA is rapidly degraded upon cell division
The rapid decline of Fzr mRNA after release from the
nocodazole arrest (Fig. 1C) suggested that this message is
very unstable. To test the stability of Fzr mRNA we treated
cells released from nocodazole arrest with the transcription
inhibitor Actinomycin D (ActD) and harvested them for
Northern blotting. Fig. 3 shows that Fzr mRNA rapidly de-
clined and was undetectable after 1 h. There was no di¡erence
in the decay of the message between cells treated with ActD or
untreated cells, showing that Fzr indeed ceased to be tran-
scribed upon release from the prometaphase block. Fzy mes-
sage declined much slower and, like Fzr, was not a¡ected by
ActD indicating that it too was not transcribed. We reprobed
our membranes a third time using a probe to detect the labile
myc message and, as expected, it rapidly declined only in
samples prepared from the ActD treated cells.
We next checked whether Fzr message is also labile during
other phases of the cell cycle. Cells were synchronized in mi-
tosis and released for 6, 10 or 14 h representing G1, S and G2
phase respectively. They were then treated with ActD and
harvested at the indicated time points. The samples were an-
alyzed by Northern blotting and the membranes were re-
probed with the myc probe. Fig. 4 shows that the Fzr message
is stable during S and G2 and slightly less stable in G1. The
message was also stable in cells arrested in prometaphase by
nocodazole, in telophase by the expression of indestructible
cyclin B1, and obviously also in unsynchronized cells. Inter-
estingly, also the myc message was stabilized in nocodazole, a
phenomenon which has not been reported in the past.
In S and G2 there was little di¡erence in Fzr mRNA levels
between cells treated with ActD for 2 h and untreated control
cells. This does not only indicate that the mRNA is very
stable, but might further suggest that Fzr is not transcribed
during these phases of the cell cycle. To clarify this point we
are currently cloning the Fzr promoter in order to study its
transcription directly.
4. Discussion
Fizzy (Fzy) and Fizzy-related (Fzr) genes interact with, and
activate the cyclosome in a cell cycle speci¢c manner
([25,26,36], T.L. and M.B., submitted). While these interac-
tions are largely regulated by phosphorylation ([31,37,38],
T.L and M.B., submitted), the role of other mechanisms, in
particular of cell cycle speci¢c expression of these genes, can-
not be excluded. The level of Fzy, which oscillates sharply
during the cell cycle was shown to be regulated by proteasome
dependent proteolysis [24]. We show here that Fzy is further
regulated by cell cycle speci¢c transcription in a manner very
similar to those of the mitotic B type cyclins.
In contrast, the observed expression pattern of Fzr mRNA
and protein is, to some extent, reminiscent of that of Cdk1
(p34cdc2) [39], both are transcriptionally regulated, the mRNA
of both is degraded rapidly upon cell division and both the
Fzr and the Cdk1 proteins are stable and present throughout
the cell cycle. There is however at least one important di¡er-
ence: Cdk1 mRNA is neither present nor transcribed in cells
arrested in G0 by serum starvation in contrast to Fzr which is
transcribed in G0. Fzr shows therefore a novel transcription
pattern which suggests that its promoter will have both cell
cycle speci¢c, as well as quiescent speci¢c, elements. Cell cycle
speci¢c stability of mRNA has also been reported for cyclin
B1 [29], however the degradation of Fzr mRNA upon cell
division we report here is even more pronounced. This might
be an interesting mechanism of cell cycle regulation which has
hardly been addressed so far.
The cell cycle speci¢c transcription and rapid degradation
of Fzr mRNA are puzzling in view of the rather constant
levels of Fzr protein during the cell cycle. Fzr activates the
cyclosome in G1 [15]. A speculative explanation for the sup-
pression of its synthesis during early G1 could therefore sug-
gest that there is a di¡erence between freshly synthesized and
old Fzr. As wild as this speculation may sound, it has already
been suggested in the past for Cdk1 which also presents a
Fig. 2. Fzr is expressed at high levels in serum starved cells, in the
brain and in testis. Total RNA was extracted from serum starved
cells (G0), hydroxyurea arrested cells (S) and from various mouse
tissues: brain (Br), heart (He), kidney (Ki), liver (Li), testis (Te) and
spleen (Sp), blotted, and probed with an Fzr speci¢c 32P-labeled
probe.
Fig. 3. Fzr mRNA is rapidly degraded upon release from a prome-
taphase block. NIH3T3 ¢broblasts were released from a nocodazole
block and cultured in fresh medium with or without ActD. Cells
were harvested at the indicated time points for Northern blotting
with a 32P-labeled Fzr speci¢c probe, stripped and hybridized with a
32P-labeled Fzy probe and stripped again and hybridized with a
32P-labeled myc probe. The image of the gel stained with ethidium
bromide showing the 28S ribosomal band is included to show the
relative amount of RNA in each lane.
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pattern of coordinated synthesis and degradation [40]. More-
over both Fzy [24] and Fzr [26] have been shown to be phos-
phorylated in a cell cycle speci¢c manner. These data should
therefore be kept in mind when studying Fzr which is prob-
ably controlled in a much more complex way than currently
believed.
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